| Erscheinungsdatum | Titel | Autor(en) |
| 2023 | Implementation and evaluation of an e-learning training concept for the imple- mentation of the German occupational dis- eases legal changes regarding the occupa- tional disease number 5101 | Symanzik, C.; Altenburg, C.; Awe, S.; Palsherm, K.; Marx, M.; Drechsel-Schlund, C.; Nienhaus, A.; Brandenburg, S.; Skudlik, C. ; John, S. M. |
| 2022 | Indication and Reimbursement of Costs for Biologics in professional Association Treatment by using the example of Dupilumab: A Basis for Discussion | Symanzik, C.; Altenburg, C.; Awe, S.; Drechsel-Schlund, C.; Nienhaus, A.; Brandenburg, St; Skudlik, C. ; John, S. M. |
| 2022 | Novel systemic medications-especially for treatment of atopic dermatitis-within therapies of the employer?s liability insur- ance association-a basis for discussion | Symanzik, C.; Altenburg, C.; Awe, S.; Drechsel-Schlund, C.; Nienhaus, A.; Brandenburg, S.; Skudlik, C. ; John, S. M. |
| 2008 | Prevalence of hand eczemas in the old-age care - First results of the KRISTA-study | Skudlik, C. ; Dulon, M.; John, S. M. ; Nienhaus, A. |
| 2009 | Prevention of occupational skin disease: a workplace intervention study in geriatric nurses | Dulon, M.; Pohrt, U.; Skudlik, C. ; Nienhaus, A. |
| 2022 | Recommendation: Indication and cost coverage for biologics within therapies of the employer's liability insurance association by the example of Dupilumab: a basis for discussion | Symanzik, C.; Altenburg, C.; Awe, S.; Drechsel-Schlund, C.; Nienhaus, A.; Brandenburg, St; Skudlik, C. ; John, S. M. |
| 2022 | Recommendation: Indication and cost coverage for biologics within therapies of the employer's liability insurance association by the example of Dupilumab: A basis for discussion [Indikation und Kostenübernahme von Biologika im berufsgenossenschaftlichen Heilverfahren am Beispiel von Dupilumab: Eine Diskussionsgrundlage] | Symanzik, C.; Altenburg, C.; Awe, S.; Drechsel-Schlund, C.; Nienhaus, A.; Brandenburg, St.; Skudlik, C. ; John, S.M. |
| 2022 | Recommendation: long-term therapy of occupational hand eczema with alitretinoin within therapies of the employer's liability insurance association | Symanzik, C.; Altenburg, C.; Awe, S.; Drechsel-Schlund, C.; Nienhaus, A.; John, S. M. |
| 2023 | Semipermeable gloves in the prevention of occupational skin diseases: Potentials and limitations | Heichel, T.; Sonsmann, F. K.; John, S. M. ; Nienhaus, A.; Nordheider, K.; Wilke, A.; Brans, R. |
| 2010 | Validation of the Osnabrück Handeczema severity index [Validierung des Osnabrück Handekzem-Schwere-Index] | Dulon, M.; Nübling, M.; Skudlik, C. ; Nienhaus, A. |
| 2009 | Validity and responsiveness of the Osnabruck Hand Eczema Severity Index (OHSI): a methodological study | Dulon, M.; Skudlik, C. ; Nuebling, M.; John, S. M. ; Nienhaus, A. |
HOCHSCHULBIBLIOGRAPHIE